Advertisement

Topics

UK NICE recommends Janssen’s Ustekinumab treatment for Crohn’s disease

19:00 EDT 18 Jun 2017 | Pharmaceutical Technology

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Janssen’s Ustekinumab for the treatment of patients with moderate-to-severe Crohn’s disease.

Original Article: UK NICE recommends Janssen’s Ustekinumab treatment for Crohn’s disease

NEXT ARTICLE

More From BioPortfolio on "UK NICE recommends Janssen’s Ustekinumab treatment for Crohn’s disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...